Compare · ALC vs COO
ALC vs COO
Side-by-side comparison of Alcon Inc. (ALC) and The Cooper Companies Inc. (COO): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ALC and COO operate in Ophthalmic Goods (Health Care), so they compete in similar markets.
- ALC is the larger of the two at $33.27B, about 1.7x COO ($19.03B).
- Over the past year, ALC is down 12.2% and COO is down 19.1% - ALC leads by 6.9 points.
- COO has been more active in the news (6 items in the past 4 weeks vs 3 for ALC).
- Both have 25 recent analyst ratings on file.
- Company
- Alcon Inc.
- The Cooper Companies Inc.
- Price
- $66.18-0.59%
- $57.91+0.88%
- Market cap
- $33.27B
- $19.03B
- 1M return
- +1.52%
- +7.66%
- 1Y return
- -12.24%
- -19.14%
- Industry
- Ophthalmic Goods
- Ophthalmic Goods
- Exchange
- NYSE
- NYSE
- IPO
- 2019
- News (4w)
- 3
- 6
- Recent ratings
- 25
- 25
Alcon Inc.
Alcon, Inc., an eye care company, researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. The company's Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for use in surgical procedures. Its cataract products include centurion vision system, LenSx femtosecond laser, LuxOR surgical ophthalmic microscope, NGENUITY 3D visualization system, and ORA system for intra-operative measurements; custom pak surgical procedure packs; vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, and grieshaber and MIVS instruments, as well as scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit vitrectomy probes; refractive surgery products, including WaveLight lasers and Contoura Vision used for LASIK treatment; and EX-PRESS glaucoma filtration device; and implantables products, including AcrySof IQ IOLs products include monofocal IOLs and advanced technology IOLs under PanOptix and ReSTOR brands for the correction of presbyopia and astigmatism at the time of cataract surgery. Its Vision Care segment provides daily disposable, reusable, and color-enhancing contact lenses; ocular health products, including devices and over-the-counter products for dry eye, over-the-counter products for contact lens care, and ocular allergies; and ocular vitamins and redness relievers under the TOTAL, PRECISION, DAILIES AquaComfort PLUS, Air Optix, Opti-Free, Clear Care, Tears Naturale, Genteal, ICAPS, and Vitalux brands. The company was formerly known as Alcon Universal S.A. and changed the name to Alcon, Inc. in December 2001. Alcon, Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.
The Cooper Companies Inc.
The Cooper Companies, Inc. operates as a medical device company worldwide. It operates through two segments, CooperVision and CooperSurgical. The company develops, manufactures, and markets a range of contact lenses, including spherical lenses, and toric and multifocal lenses that correct near- and farsightedness, as well as addresses various complex visual defects, such as astigmatism and presbyopia. It also provides range of products and services for enhancing health of women, babies, and families, including medical devices, fertility, genomics, and diagnostics and contraception for hospitals and surgical centers, obstetricians' and gynecologists' (OB/GYNs) medical offices, and fertility clinics. In addition, the company develops mechanical surgical solutions for skin closure; and offers PARAGARD, a contraceptive, as well as provides assisted reproductive technology products, genetic screening and testing, and products within the general OB/GYN offerings. It markets its products under Biofinity, clariti 1day, MyDay, Avaira Vitality, and Proclear 1 Day brand name through a network of field sales representatives, independent agents, eye care practitioners, and distributors. The Cooper Companies, Inc. was founded in 1980 and is headquartered in San Ramon, California.
Latest ALC
- FDA Approves Alcon’s BRYTLY Redness Reliever Eye Drops for Up to 12 Hours of Whiter, Brighter-Looking Eyes
- Barclays initiated coverage on Alcon with a new price target
- Introducing Systane® PRO PRESERVATIVE-FREE: Alcon’s Longest Lasting, Triple-Action Formula for up to 12 Hours of Dry Eye Symptom Relief
- Alcon Launches UNITY M, a Premium Ophthalmic Microscope Delivering Precise Control
- Alcon Prices EUR 500 Million Senior Notes Offering
- Alcon downgraded by BNP Paribas Exane with a new price target
- SEC Form 6-K filed by Alcon Inc.
- New Product Launches and Strong Commercial Execution Drive Alcon's Second-Quarter 2026 Growth
- Alcon and RxSight Announce Collaboration to Develop Adjustable PCIOLs
- SEC Form SD filed by Alcon Inc.
Latest COO
- Barclays initiated coverage on Cooper with a new price target
- New CooperVision® Consumer Insights Report Reveals Multifocal Contact Lenses Are Viewed as a Leading Anti-Aging Solution
- Seneca Polytechnic and CooperVision Canada open Contact Lens Centre of Excellence to help advance the future of vision care
- COOPER COMPANIES, INC. COO INVESTORS: Contact Kirby McInerney LLP About the Firm’s Securities Investigation Following 14.7% Share Drop
- CooperCompanies Unveils Accelerated CooperVision Innovation Strategy at The Vision Centre Opening
- CooperVision Powers the Next Era of Eye Care with New Global Vision Centre and Major Pipeline Advancements
- JANA Partners Sends Letter to Cooper Board of Directors
- Director Kurzius Lawrence Erik bought $549,320 worth of shares (10,000 units at $54.93), increasing direct ownership by 47% to 31,099 units (SEC Form 4)
- Director Rosebrough Walter M Jr bought $541,640 worth of shares (10,000 units at $54.16) (SEC Form 4)
- Director Kurzius Lawrence Erik bought $539,150 worth of shares (10,000 units at $53.91), increasing direct ownership by 90% to 21,099 units (SEC Form 4)